These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10618534

  • 1. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice.
    Ruitenberg KM, Walker C, Love DN, Wellington JE, Whalley JM.
    Vaccine; 2000 Jan 31; 18(14):1367-73. PubMed ID: 10618534
    [Abstract] [Full Text] [Related]

  • 2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474
    [Abstract] [Full Text] [Related]

  • 3. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):59-66. PubMed ID: 16473414
    [Abstract] [Full Text] [Related]

  • 4. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection.
    Ruitenberg KM, Walker C, Wellington JE, Love DN, Whalley JM.
    Vaccine; 1999 Jan 21; 17(3):237-44. PubMed ID: 9987159
    [Abstract] [Full Text] [Related]

  • 5. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease.
    Ruitenberg KM, Gilkerson JR, Wellington JE, Love DN, Whalley JM.
    Virus Res; 2001 Nov 05; 79(1-2):125-35. PubMed ID: 11551653
    [Abstract] [Full Text] [Related]

  • 6. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
    Learmonth GS, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Arch Virol; 2003 Sep 05; 148(9):1805-13. PubMed ID: 14505091
    [Abstract] [Full Text] [Related]

  • 7. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA, Stanfield BA, Chouljenko VN, Naidu S, Langohr I, Del Piero F, Ferracone J, Roy AA, Kousoulas KG.
    J Virol; 2017 Jun 15; 91(12):. PubMed ID: 28404844
    [Abstract] [Full Text] [Related]

  • 8. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
    Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR.
    Virology; 1995 Apr 20; 208(2):500-10. PubMed ID: 7747423
    [Abstract] [Full Text] [Related]

  • 9. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
    Ruitenberg KM, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Vet Microbiol; 2000 Sep 25; 76(2):117-27. PubMed ID: 10946142
    [Abstract] [Full Text] [Related]

  • 10. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D, Whalley JM, Love DN, Field HJ.
    J Gen Virol; 1994 Jul 25; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [Abstract] [Full Text] [Related]

  • 11. Potential of DNA-mediated vaccination for equine herpesvirus 1.
    Ruitenberg KM, Walker C, Wellington JE, Love DN, Whalley JM.
    Vet Microbiol; 1999 Aug 16; 68(1-2):35-48. PubMed ID: 10501160
    [Abstract] [Full Text] [Related]

  • 12. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
    Zhao Y, Chang J, Zhang B, Tong P, Wang C, Ran D, Su Y.
    Arch Virol; 2019 May 16; 164(5):1371-1382. PubMed ID: 30888564
    [Abstract] [Full Text] [Related]

  • 13. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
    Packiarajah P, Walker C, Gilkerson J, Whalley JM, Love DN.
    Vet Microbiol; 1998 Apr 15; 61(4):261-78. PubMed ID: 9646476
    [Abstract] [Full Text] [Related]

  • 14. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 15. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
    Kukreja A, Walker C, Fitzmaurice T, Awan A, Love DN, Whalley JM, Field HJ.
    Vet Microbiol; 1998 Aug 15; 62(4):303-11. PubMed ID: 9791876
    [Abstract] [Full Text] [Related]

  • 17. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
    Csellner H, Walker C, Wellington JE, McLure LE, Love DN, Whalley JM.
    Arch Virol; 2000 Aug 15; 145(11):2371-85. PubMed ID: 11205124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.
    Tewari D, Nair SV, De Ungria MC, Lawrence GL, Hayden M, Love DN, Field HJ, Whalley JM.
    Arch Virol; 1995 Aug 15; 140(4):789-97. PubMed ID: 7794119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.